Pre-emptive increase in the filgrastim dose based on the CD34+ cell count on day four of autologous stem cell mobilization
Saved in:
| Main Authors: | Paulla Rayane Chaves Utsch, Fernando Barroso Duarte, Abrahão Elias Hallack Neto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924003316 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilization
by: Mehmet Bakırtaş, et al.
Published: (2025-01-01) -
Anaphylaxis from filgrastim prophylaxis within the same day of chemotherapy: A case report
by: Suluck Soontaros, et al.
Published: (2024-12-01) -
Effectiveness of filgrastim and polyethylene glycol-filgrastim in the treatment of postchemotherapy neutropenia in children: Phase I clinical trial
by: Saeed Yousofian, et al.
Published: (2019-01-01) -
Autologous CD34+ stem cell humanization in head and neck cancer modeling: The translational importance of T cell maturation
by: Joseph Zenga, et al.
Published: (2023-03-01) -
Autologous induced pluripotent stem cell-derived four-organ-chip
by: Anja Patricia Ramme, et al.
Published: (2019-09-01)